Exploratory / Discovery

Myriad RBM’s Multi-Analyte Profiles (MAPs) provide a menu of quantitative assays for over 400 biomarkers across human, mouse, and rat species. Using our expertise and multiplexing capabilities, we provide the most data using the least amount of sample volume. See the whole picture from the start to make better decisions moving forward.

Click here to request a quote or learn more about Myriad RBM’s capabilities.

Trust the data. We don’t just run kits – we develop, manufacture and validate our multiplexed assays to clinical laboratory standards. With Myriad RBM, you can move forward knowing that the data generated is sensitive, reliable and reproducible. We operate a CLIA-certified lab and can support GLP studies. Please see our Data Quality page for more information about our high quality standards.

Rely on our expertise. We’ve been doing this for over a decade, combining multiplex immunoassay technology with liquid handling automation and a clinical lab infrastructure to quickly deliver sensitive, reproducible results. Our platform provides cost-effective data supporting research at each stage of drug development. We can identify new biomarkers linked to your disease indication or the efficacy of your drug and we can provide testing services for those biomarkers throughout the development process. We also have biomarker panels with specific applications, such as KidneyMAP® for early detection of renal toxicity. Visit our bibliography to see over 150 customer publications and learn more about the proven success of Myriad RBM’s service and expertise.